In a remarkable pivot, Athira Pharma is shifting its primary focus from Alzheimer’s to oncology following a multi-year period marked by clinical failures and leadership turnover. The Bothell, ...

In this article, we will be taking a look at the 9 Most Undervalued Pharma Stocks to Buy Right Now. The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable ...

Marika Murto brings over 20 years of pharmaceutical expertise in product strategy, innovation, and business transformation Her appointment as SVP of Global Product Strategy will help unlock LEO Pharma ...

As the lowest sodium (80mg sodium for 9g dose), once-nightly treatment currently in development, TRN-257 has the potential to be the new standard of care for adults with narcolepsy (cataplexy or ...

President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to bear much of the burden of the costs of medicines. By Rebecca Robbins and Eshe Nelson ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the ...

The Supreme Court blocked an earlier version of Purdue’s bankruptcy settlement. Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no ...

Medicus Pharma is advancing Teverelix, a recently acquired, clinical stage asset, designed to address limitations of current hormone therapies for prostate cancer and benign prostatic hyperplasia (BPH ...

The Japanese company Takeda Pharmaceutical is one of the biggest employers in the Conejo Valley biotechnology sector. In Thousand Oaks, Takeda produces treatments for ultra-rare diseases, including a ...

aTyr Pharma (NASDAQ:ATYR) stock fell after its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease, did not achieve its main goal. The ...